Elyse Shapiro

Shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) rose 7 percent on Wednesday after Cowen analysts Ritu Baral and Elyse Shapiro upgraded the stock from Market Perform to Outperform, setting a $120 price target. The promotion comes in anticipation of the upcoming ACT-DMD data in the fourth quarter...